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Abstract
Background: The aim of this study was to compare the results of palpation-versus ultrasound-
guided thyroid fine-needle aspiration (FNA) biopsies.
Findings: Clinical data, cytology and histopathology results were retrospectively analyzed on all
patients who underwent thyroid FNA biopsy in our outpatient endocrinology clinic between
January 1998 and April 2003. The same investigators performed all thyroid FNAs (ASC) and
cytological evaluations (KP). Subjects in the ultrasound-guided group were older, otherwise there
were no differences in baseline characteristics (gender, thyroid function, the frequency of
multinodular goiter, nodule diameter and nodule location) between groups. Cytology results in
nodules aspirated by palpation (n = 202) versus ultrasound guidance (n = 184) were as follows:
malignant 2.0% versus 2.7% (p = 0.74), benign 69.8% versus 79.9% (p = 0.02), indeterminate 1.0%
versus 4.9% (p = 0.02), inadequate 27.2% versus 12.5% (p < 0.01). Malignant results were compared
with Fisher's exact test. Other cytology categories were compared with chi-square test. Eighteen
patients from the palpation- and 23 from ultrasound-guided group underwent surgery. In the
palpation-guided group, the sensitivity of FNA was 100%, specificity 94%, positive predictive value
67% and negative predictive value 100%. In the ultrasound-guided group, the sensitivity of FNA was
100%, specificity 80%, positive predictive value 73% and negative predictive value 100%.
Conclusion: We demonstrate that ultrasound guidance for thyroid FNA significantly decreases
inadequate for evaluation category. We also confirm the high sensitivity and specificity of thyroid
FNA biopsy in the diagnosis of thyroid cancer. Where available, we recommend universal
application of ultrasound guidance for thyroid FNA biopsy as a standard component of this
diagnostic technique.
Findings
Thyroid nodules are commonly encountered in clinical
practice. There are only two recent practice guidelines for
the management of thyroid nodules, both published in
2006. American Association of Clinical Endocrinologists
(AACE) recommends ultrasound (USG)-guided fine-nee-
dle aspiration (FNA), universally for all thyroid nodules
that are ≥ 10 mm in diameter in euthyroid subjects [1]. In
contrast, American Thyroid Association (ATA) recom-
mends either palpation- or ultrasound-guided FNA
biopsy [2]. As established guidelines differ on the utility of
ultrasound guidance, we aimed to compare the results of
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needle aspiration biopsies in our clinical case series.
Methods
We prospectively recorded the clinical information and
cytology results of all consecutive patients who underwent
FNA biopsy of thyroid nodules in the outpatient endo-
crinology clinic of our hospital in a computerized data-
base. This prospectively-maintained database was
retrospectively analyzed. All patients were examined by
ASC, an endocrinologist who also performed all thyroid
FNA biopsies between January 1998 and April 2003. Thy-
roid function tests and thyroid ultrasonography were rou-
tinely obtained. Free thyroxine (kit: FT4), free
triiodothyronine (kit: FT3) and TSH (kit: TSH) were meas-
ured with electrochemiluminescence immunoassay in an
Elecsys autoanalyzer. Kits and the autoanalyzer were sup-
plied by the Turkish distributor of Roche Diagnostics,
Indianapolis, IN, USA. Subjects were classified into euthy-
roid, hypothyroid and hyperthyroid categories according
to the results of thyroid function tests. Thyroid scintigra-
phy with Technetium-99m was routinely obtained for all
subjects who had low TSH levels and in some euthyroid
subjects. Five patients had hyperactive nodules in thyroid
scintigraphy and were excluded from this analysis. There
were 299 subjects with thyroid nodules. Two hundred and
twenty patients had a solitary thyroid nodule and 79
patients had a multinodular goiter. An ultrasound system
(Ultramark 4+, Advanced Technology Laboratories,
Washington, USA) with a 7.5 MHz linear array transducer
was acquired by our outpatient endocrinology clinic in
August 1999 and was used for all USG-guided biopsies
since then. Seventy percent of palpation-guided biopsies
were performed between January 1998 and August 1999
and 30% (n = 60) afterwards, at times when ultrasound
system was temporarily unavailable. A published stand-
ard technique was used for palpation-guided FNA biop-
sies, performed by the investigator ASC [3]. All of the
ultrasound-guided biopsies were performed between
August 1999 and April 2003. The same investigator (ASC)
performed all USG-guided biopsies with 22 or 26 G nee-
dles according to a previously published technique [4].
Local anesthesia with 2% lidocaine was routinely admin-
istered for both palpation- and USG-guided FNAs. Two
needle aspirations were carried out for each nodule. If the
material was judged macroscopically insufficient, up to
four aspirations were performed to obtain additional
material. On-site microscopic adequacy was not evalu-
ated. Half of the slides were air-dried and stained with
May-Grünwald-Giemsa and the other half were alcohol-
fixed and stained with Hematoxylene-Eosine or Papanico-
laou. The same investigator (KP) has evaluated all cytolog-
ical smears. Cytological diagnoses were classified as
recommended by existing guidelines into malignant,
benign, indeterminate and inadequate for evaluation cat-
egories [2,3]. Six clusters of benign cells in at least two
slides constituted adequate material for cytological diag-
nosis. Each cluster was composed of at least 15 cells. The
smears that do not meet these criteria were assigned into
inadequate category. Indeterminate samples included a
pattern of follicular or Hurthle cell neoplasm or aspects of
atypia suggestive, but not conclusive of the presence of a
malignant neoplasm [3].
Baseline characteristics and FNA results of ultrasound-
guided and palpation-guided groups were compared. Par-
ametric variables were presented as mean ± standard devi-
ation and Student's t test was used for comparison.
Because of its positively skewed distribution, logarithmic
transformation of nodule diameter was used in Student's
t test. Categorical variables were presented as percentages
and chi-square test was used for comparison. Because the
expected frequencies of malignant results were less than
five in both groups, each cytology category in palpation-
and USG-guided groups was compared by chi-square test
after collapsing the rest of the categories. Fisher's exact test
was employed when the expected frequencies were less
than five. Malignant and indeterminate FNA cytology
results were categorized into positive tests in construction
of 2 × 2 tables in the calculation of sensitivity and specifi-
city, as surgery is recommended to patients with such
results. Benign and inadequate cytology results were cate-
gorized into negative tests, as surgery is not recommended
in these circumstances. In 2 × 2 tables, benign and malig-
nant surgical histopathology results were categorized as
negative and positive disease, respectively. The study was
approved by the Scientific Research Review Board of
Vehbi Koc Foundation American Hospital. As this analysis
was based on a clinical case series and the subjects were
patients who seek medical care, the informed consent was
for the performance of thyroid FNA biopsy. Informed
consent to perform thyroid FNA was obtained from all
subjects in accordance with the hospital bylaws and Turk-
ish Ministry of Health rules. The study was in compliance
with the Helsinki Declaration.
Results
In the palpation group, 126 patients had a solitary nod-
ule, 35 patients had two nodules and 2 patients had three
nodules, hence 202 FNAs were performed by palpation.
In the ultrasound-guided group, 94 patients had a solitary
nodule, 36 patients had two nodules and 6 patients had
three nodules, hence 184 FNAs were performed with
ultrasound-guidance. Subjects in the ultrasound-guided
group were older, otherwise there were no differences in
baseline characteristics (gender, thyroid function, the fre-
quency of MNG, nodule diameter and nodule location)
between the palpation- and ultrasound-guided groups, as
shown in Table 1 and 2. In both palpation-guided and
USG-guided hyperthyroid subgroups, four subjects hadPage 2 of 5
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ers. All hyperthyroid subjects had hypoactive nodules on
thyroid scintigraphy. In the palpation group 4 (2%) biop-
sies were malignant, 141 (70%) benign and 2 (1%) inde-
terminate. In the ultrasound-guided group 5 (3%)
biopsies were malignant, 147 (80%) benign and 9 (5%)
indeterminate. The rate of malignancy was similar
whether or not fine-needle aspiration biopsy was per-
formed manually or under ultrasound guidance. Signifi-
cantly more patients had benign and indeterminate
results in the USG-guided group. Twenty-seven percent
(55/202) of palpation-guided and 13% (23/184) of ultra-
sound-guided biopsies were inadequate for evaluation (χ
2:12.95, df: 1, p = 0.0003). Eighteen subjects from the pal-
pation- and 23 subjects from the ultrasound-guided group
underwent thyroid surgery. In the palpation group, his-
topathology showed two papillary thyroid carcinomas
which were also malignant in prior cytology and were true
positives. There were no false negative results in palpa-
tion-guided biopsies. There were 16 nodules that were
benign in histopathology. Twelve of them were classified
as benign, three as inadequate (a total of 15 true nega-
tives) and one as indeterminate (false positive) in prior
FNA biopsy. The false positive cytology result was found
to be a Hurthle cell adenoma in surgical histopathology.
In the palpation-guided group, the sensitivity of FNA was
100%, specificity 94%, positive predictive value 67% and
negative predictive value 100%. In the ultrasound-guided
group, histopathology after thyroidectomy showed seven
papillary and one follicular thyroid cancers. From these,
five nodules were malignant and three were indetermi-
nate in prior cytology, so all of them were true positives.
There were also no false negative results in ultrasound-
guided biopsies. There were 15 nodules that were benign
in final histopathology. Eleven of them were classified as
benign and one as inadequate in prior FNA biopsy, so
there were 12 true negatives. There were three indetermi-
nate FNAs that were benign in final histopathology, two
follicular adenomas and one adenomatous nodule and
these were false positives. In the ultrasound-guided group,
the sensitivity of FNA was 100%, specificity 80%, positive
predictive value 73% and negative predictive value 100%.
Discussion
Fine-needle aspiration biopsy is an essential diagnostic
tool in the management of thyroid nodules. FNA can dis-
tinguish benign from malignant nodules and this has
resulted in a large decrease in the number of patients
undergoing surgery for excision of benign thyroid nodules
and increased the cancer yield at surgery [1,2,5]. It is
reported that 9 to 47% of palpation-guided and 4 to 21%
of ultrasound-guided FNA smears are inadequate [6-13].
Hatada and coworkers reported that for nodules less than
2 cm in diameter, the sensitivity and accuracy of USG-
guided FNA biopsies are significantly better than manual
FNA [12]. Mehrotra and coworkers reported an unsatisfac-
tory specimen rate of 46.8% for palpation-guided FNAs
and 15.6% for USG-guided core-cutting needle aspira-
tions [8]. From a large study with 9683 subjects, Danese
and coworkers reported the sensitivity, specificity and
accuracy of palpation-guided thyroid FNAs as 91.8%,
Table 1: Comparison of baseline characteristics between 
subjects who underwent palpation-guided and ultrasound-guided 
thyroid fine-needle aspiration biopsies
Palpation-guided Ultrasound-guided P-value
Subjects (n) 163 136
Age (years)* 40 ± 12 44 ± 14 0.01
Men (%)† 23 (14%) 24 (18%) 0.40
Women (%)† 140 (86%) 112 (82%) 0.40
Euthyroid (%)† 151 (93%) 122 (90%) 0.61
Hypothyroid (%)† 5 (3%) 7 (5%) 0.61
Hyperthyroid (%)† 7 (4%) 7 (5%) 0.61
Solitary nodule (%)† 126 (77%) 94 (69%) 0.11
MNG (%)†‡ 37 (23%) 42 (31%) 0.11
*mean and standard deviation are given and Students' t test is used in 
comparison †Categorical variables are expressed as percentages and 
chi-square test was used in comparison ‡MNG: multinodular goiter
Table 2: Comparison of nodule diameter, location and cytology between palpation-guided and ultrasound-guided thyroid fine-needle 
aspiration biopsies
Palpation-guided Ultrasound-guided P-value
Nodule number (n) 202 184
Log(nodule diameter in mm)* 1.22 ± 0.16 1.22 ± 0.21 0.71
Right thyroid lobe (%)† 95 (47%) 76 (41%) 0.08
Left thyroid lobe (%)† 81 (40%) 93 (51%) 0.08
Isthmus (%)† 26 (13%) 15 (8%) 0.08
Malignant (%)‡ 4 (2.0%) 5 (2.7%) 0.74
Benign (%)† 141 (69.8%) 147 (79.9%) 0.02
Indeterminate (%)† 2 (1.0%) 9 (4.9%) 0.02
Inadequate (%)† 55 (27.2%) 23 (12.5%) 0.0003
*mean and standard deviation are given and Students' t test is used in comparison †Categorical variables are expressed as percentages and chi-
square test was used in comparison ‡Fisher's exact test was used in comparisonPage 3 of 5
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70.9% and 75.6%, respectively [11]. The studies that com-
pared palpation- and ultrasound-guided thyroid FNA
biopsies were illustrated in table 3. There are wide differ-
ences in the rate of inadequate smears between studies.
These differences could be attributed to the difference in
the experience of the aspirating physician and the
cytopathologist, and in the definition of an inadequate
specimen among studies. A successful thyroid FNA
requires an adequate specimen, high-quality smear prep-
aration, and experience on the part of the both aspirator
and cytopathologist [4]. In our study, all of the FNA biop-
sies were performed by the same endocrinologist (ASC)
and all of the smears were read by the same pathologist
(KP). Some previous studies that compared palpation-
and ultrasound-guided FNAs included fewer number of
nodules than our study [7,8,10,12]. In other previous
studies, either the cytology or the aspiration were per-
formed by different investigators [5,8,9,11,13]. In our
study, the allocation to palpation- and ultrasound-guided
groups was not random and was based on a certain time
period, constituting a limitation for the interpretation of
results. Ideally, comparison of different diagnostic meth-
ods should be performed on the same subject, at the same
time, by the same aspirating physician, and the same
cytopathologist should interpret all smears, as conducted
in a prospective study by Cesur et al [7]. That study proved
the superiority of ultrasound-guided thyroid FNA biopsies
over palpation-guided FNA biopsies [7]. In clinical prac-
tice, it is recommended that ultrasound guidance should
be sought after a failed manual thyroid FNA, in small nod-
ules (less than 15 mm in diameter), in nonpalpable nod-
ules, in lesions that are located in difficult-to-access
locations, in nodules with extensive cystic change, fibrosis
or calcification [3,6,11,14]. Ultrasound guidance is also
helpful in directing the needle to solid portions of the
cystic or mixed nodules and reduces the need for repeat
FNAs [14]. Our results indicate that ultrasound-guided
thyroid FNA cytology provides fewer unsatisfactory sam-
ples than palpation-guided thyroid FNAs. A decrease in
the inadequate specimen rate is anticipated to improve
the diagnostic accuracy of thyroid FNA biopsy. Ghofrani
and coworkers reported that on-site adequacy assessment
reduced the rate of inadequate smears from 12% to 7% in
palpation-guided; from 7% to 5% in ultrasound-guided
biopsies [9]. We did not have on-site assessment of FNA
biopsies, a process that may have improved our diagnostic
yield. In a recent study, Orija et al. reported the prevalence
of thyroid cancer as 8.5% in patients with unsatisfactory
FNAs and recommended the performance of at least two
repeat FNA biopsies with ultrasound-guidance for initial
inadequate smears [15]. As summarized in table 3, all
published studies that compare palpation-guided with
USG-guided FNAs show the superiority of the latter.
Therefore, practice guidelines should universally recom-
mend ultrasound-guided FNA biopsies in the manage-
ment of thyroid nodules. Further studies should analyze
cost-effectiveness of palpation-versus USG-guided thyroid
FNAs.
Conclusion
We have demonstrated that utilization of ultrasound
guidance for thyroid FNA biopsies significantly decreases
inadequate for evaluation category. We also confirm the
high sensitivity and specificity of thyroid FNA biopsy in
the diagnosis of thyroid cancer. In view of our results,
where available, we recommend universal application of
ultrasound guidance for thyroid fine-needle aspiration
biopsy, as a standard component of this diagnostic tech-
nique.
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Table 3: Inadequate biopsy rates in studies that compared palpation-guided versus ultrasound-guided thyroid fine-needle aspiration 
biopsies
Author and year No. of nodules Palpation-guided Ultrasound-guided Reference
Danese 1998 9683 9% 4% [11]
Hatada 1998 166 30% 17% [12]
Carmeci 1998 497 16% 7% [5]
Mehrotra 2005 262 47% 16% [8]
Ghofrani 2006 1502 17% 7% [9]
Cai 2006 434 13% 6% [13]
Cesur 2006 285 32% 21% [7]
Izquierdo 2006 376 11% 7% [10]
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